Mefloquine for preventing malaria in non-immune adult travellers.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2000-10-23

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/14651858.CD000138PMID 10908460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropsychiatric problems in 2,500 long-term young travelers to the tropics.

  2006cited by this paper
• Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.

  2006cited by this paper
• Mefloquine concentration profiles during prophylactic dose regimens.

  2000cited by this paper
• Malaria: prevention in travellers

  2000cited by this paper
• [Mefloquine and ototoxicity: a report of 3 cases].

  1999cited by this paper
• Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports

  1999cited by this paper
• [Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].

  1999cited by this paper
• Epidemiology of Malaria in the British Army from 1982-1996

  1999cited by this paper
• Prophylaxis against malaria. More studies of mefloquine prophylaxis must be done in tourists.

  1999cited by this paper
• Handsearching the Journal of the Royal Army Medical Corps for Trials

  1999cited by this paper
• Canadian military malarial prophylaxis under scr utiny

  1999cited by this paper
• Antimalarial prophylaxis--use and adverse events in visitors to the Kruger National Park.

  1999cited by this paper
• Malaria prevention for travelers.

  1998cited by this paper
• [Convulsions during prophylactic use of mefloquine].

  1998cited by this paper
• [Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].

  1998cited by this paper
• Tolerance of mefloquine by SwissAir trainee pilots.

  1997cited by this paper
• Consumer participation in research and health care

  1997cited by this paper
• Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis.

  1997cited by this paper
• Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication.

  1997cited by this paper
• How to read a paper: Papers that report drug trials

  1997cited by this paper
• Neuro-psychiatric effects of antimalarials

  1997cited by this paper
• Including elderly people in clinical trials

  1997cited by this paper
• Mefloquine Compared with Doxycycline for the Prophylaxis of Malaria in Indonesian Soldiers

  1997cited by this paper
• Why "underpowered" trials are not necessarily unethical.

  1997cited by this paper
• Making malaria research bite

  1997cited by this paper
• Exclusion of elderly people from clinical research: a descriptive study of published reports

  1997cited by this paper
• Mefloquine to prevent malaria: a systematic review of trials

  1997cited by this paper
• Large trials vs meta-analysis of smaller trials.

  1997cited by this paper
• Evidence-based medicine and general practice.

  1997cited by this paper
• [Malaria prophylaxis. Effects and side-effects of drugs used for prevention of malaria].

  1997cited by this paper
• Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial.

  1997cited by this paper
• Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine.

  1997cited by this paper
• Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance

  1996cited by this paper
• Influences on the Quality of Published Drug Studies

  1996cited by this paper
• Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers

  1996cited by this paper
• Neuropsychiatric reactions with mefloquine chemoprophylaxis.

  1996cited by this paper
• [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration].

  1996cited by this paper
• Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial.

  1996cited by this paper
• Developing evidence-based clinical practice guidelines: lessons learned by the US Preventive Services Task Force.

  1996cited by this paper
• User Acceptability Patterns for Mefloquine and Doxycycline Malaria Chemoprophylaxis.

  1996cited by this paper
• Effects of mefloquine alone and with alcohol on psychomotor and driving performance

  1996cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• Randomised trials, human nature, and reporting guidelines.

  1996cited by this paper
• Uncertainty about mefloquine will take time to resolve.

  1996cited by this paper
• Better reporting of randomised controlled trials: the CONSORT statement

  1996cited by this paper
• Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: The Mangochi Malaria Research Project.

  1996cited by this paper
• Malaria Chemoprophylaxis in German Tourists: A Prospective Study on Compliance and Adverse Reactions.

  1996cited by this paper
• Patients may start to take cheaper over the counter regimens

  1996cited by this paper
• Field trials of health interventions in developing countries : a toolbox

  1996cited by this paper
• Women may be more susceptible to adverse events

  1996cited by this paper
• North of England evidence based guidelines development project: methods of guideline development

  1996cited by this paper
• Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients.

  1995cited by this paper
• An evidence based approach to individualising treatment

  1995cited by this paper
• Prophylaxis against malaria

  1995cited by this paper
• CNS Adverse Events Associated With Antimalarial Agents

  1995cited by this paper
• Mefloquine in malaria prophylaxis: low efficacy or low compliance?

  1995cited by this paper
• Mefloquine in the Prophylaxis of P. Falciparum Malaria.

  1995cited by this paper
• Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.

  1995cited by this paper
• Vitamin E deficiency

  1995cited by this paper
• Targets are suggestions to be modified

  1995cited by this paper
• Toxicity of mefloquine is similar to that of other chemoprophylaxis

  1995cited by this paper
• A model for adapting clinical guidelines for electronic implementation in primary care.

  1995cited by this paper
• Systematic Reviews: Identifying relevant studies for systematic reviews

  1994cited by this paper
• Acute brain syndrome after mefloquine treatment

  1994cited by this paper
• Malaria prophylaxis: identifying risk groups for non-compliance.

  1994cited by this paper
• Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study.

  1994cited by this paper
• Confused malaria chemoprophylaxis

  1994cited by this paper
• Who benefits from medical interventions?

  1994cited by this paper
• Neuropsychiatrische Störungen nach Malariaprophylaxe mit Mefloquin

  1994cited by this paper
• MALARIA CHEMOPROPHYLAXIS. AUTHOR'S REPLY

  1993cited by this paper
• Neuralgic amyotrophy after parvovirus B19 infection.

  1993cited by this paper
• Searching the literature. Be systematic in your searching.

  1993cited by this paper
• Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.

  1993cited by this paper
• Cardiac effects of antimalarial treatment with halofantrine.

  1993cited by this paper
• Letters to the EditorMalaria chemoprophylaxis

  1993cited by this paper
• Long-term malaria prophylaxis with weekly mefloquine.

  1993cited by this paper
• Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

  1993cited by this paper
• [Mefloquine chemoprophylaxis of malaria in the Brazilian Amazonia].

  1993cited by this paper
• Guidance on guidelines.

  1992cited by this paper
• Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.

  1992cited by this paper
• [Psychotic episode caused by prevention of malaria with mefloquine. A case report].

  1992cited by this paper
• Getting to grips with Archie Cochrane's agenda.

  1992cited by this paper
• High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.

  1992cited by this paper
• Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.

  1992cited by this paper
• Antimalarial drug resistance: the pace quickens.

  1992cited by this paper
• Computer-generated physician and patient reminders. Tools to improve population adherence to selected preventive services.

  1991cited by this paper
• Neuropsychiatric side effects after the use of mefloquine.

  1991cited by this paper
• Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.

  1991cited by this paper
• A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis.

  1990cited by this paper
• Malaria chemoprophylaxis: why mefloquine?

  1990cited by this paper
• Guidelines for Policy Statements: the Explicit Approach

  1990cited by this paper
• Malaria incidence and prevention among European and North American travellers to Kenya.

  1990cited by this paper
• Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.

  1989cited by this paper
• The effectiveness of chemoprophylaxis against malaria for non-immune migrant workers in eastern Thailand.

  1989cited by this paper
• Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.

  1989cited by this paper
• Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.

  1988cited by this paper
• The use of immunofluorescence to evaluate the efficacy of malarial chemoprophylaxis.

  1987cited by this paper
• [Practical experience with mefloquine as an antimalarial].

  1986cited by this paper
• Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

  1986cited by this paper
• Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis.

  1986cited by this paper

• Deaths and parasuicides associated with mefloquine chemoprophylaxis: A systematic review.

  2017cites this paper
• Stimulation of Suicidal Erythrocyte Death by the Antimalarial Drug Mefloquine

  2015cites this paper
• NEURO-PSYCHIATRIC ILLNESS, BRAIN INJURY, NEUROTOXIC DRUGS AND MORAL INJURY IN AUSTRALIAN DEFENCE FORCE VETERANS Submission the Inquiry into the Mental Health of Australian Defence Force Personnel

  2015cites this paper
• Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force

  2015influential citation
• Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey

  2013cites this paper
• Severity of imported malaria: protective effect of taking malaria chemoprophylaxis

  2013cites this paper
• Malaria Chemoprophylaxis for the International Traveler, Current Options and Future Possibilities

  2012cites this paper
• Health Advice for International Travel

  2011cites this paper
• A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons.

  2010cites this paper
• Granuloma Annulare : Not as Simple as It Seems

  2010cites this paper
• Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study.

  2009cites this paper
• Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice

  2009cites this paper
• Drugs for preventing malaria in travellers

  2009cites this paper
• Chemoprophylaxis and intermittent treatment for preventing malaria in children.

  2008cites this paper
• Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system.

  2008cites this paper
• Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.

  2007cites this paper
• A lesson learnt: the rise and fall of Lariam and Halfan

  2007cites this paper
• An update on malaria prevention, diagnosis and treatment for the returning traveller.

  2007cites this paper
• Controversies and misconceptions in malaria chemoprophylaxis for travelers.

  2007cites this paper
• Mefloquine Induces Dose-Related Neurological Effects in a Rat Model

  2006cites this paper
• Insect Avoidance and Malaria Chemoprophylaxis

  2005cites this paper
• Chemoprophylaxis and intermittent treatment for preventing malaria in children.

  2005cites this paper
• The Antimalarial Potential of 4-Quinolinecarbinolamines May Be Limited due to Neurotoxicity and Cross-Resistance in Mefloquine-Resistant Plasmodium falciparum Strains

  2004cites this paper
• Malaria and the traveller

  2003cites this paper
• Prevención de la malaria en los viajes internacionales

  2003cites this paper
• Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study

  2003cites this paper
• [Malaria prevention in international travel].

  2003cites this paper
• The prevention of malaria.

  2002cites this paper
• Malaria prophylaxis with atovaquone-proguanil caused fewer gastrointestinal adverse events than chloroquine-proguanil

  2001cites this paper
• Malaria: prevention in travellers

  2000influential citation